Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Armata Pharma reports positive data from phase 1b/2a diSArm study of intravenously administered AP-SA02 to treat S. aureus bacteremia: Los Angeles Tuesday, May 20, 2025, 17:00 Hrs ...

LEICESTER, England — Healthcare workers’ uniforms washed at home might be bringing dangerous bacteria back to hospitals, creating a breeding ground for drug-resistant superbugs. A new study from ...

or Methicillin-resistant Staphylococcus aureus. MRSA flourishes in hospitals, where microbes and plentiful antibiotics meet, but over time has emerged in the broader population. This pattern has been ...

MRSA represents the leading edge of antibiotic resistance The first essential ... key fact involves MRSA’s two primary epidemiological patterns. Healthcare-associated MRSA (HA-MRSA ...

even under high antibiotic concentrations. When the high methicillin concentrations successfully eliminate wild and even low-resistance MRSA strains, the remaining potentiator mutation-possessing ...

MRSA stands for Methicillin-resistant Staphylococcus aureus. It is a type of bacteria that has developed resistance to many common antibiotics, including methicillin, penicillin, and similar drugs.

aureus) bacteria with different resistance patterns. MRSA is resistant to many antibiotics and is more difficult to treat. Both types of bacteria can cause severe infections if left untreated.

Cumulatively, from 2025 to 2050, the world could see more than 39 million deaths that are directly attributable to antimicrobial resistance ... or MRSA. For this combination – the antibiotic ...